AUTHOR=Lv Wanrui , Cheng Ke , Li Xiaofen , Feng Lusi , Li Hancong , Li Jia , Chang Chen , Cao Dan 

TITLE=Case Report: Favorable Response and Manageable Toxicity to the Combination of Camrelizumab, Oxaliplatin, and Oral S-1 in a Patient With Advanced Epstein–Barr Virus-Associated Gastric Cancer

JOURNAL=Frontiers in Oncology

VOLUME=11

YEAR=2022

URL=https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.759652

DOI=10.3389/fonc.2021.759652

ISSN=2234-943X